Immunopotentiating activity of nigerooligosaccharides for the t helper 1-like immune response in mice

Bioscience, Biotechnology and Biochemistry

Volumn 63, Issue 2, 1999, Pages 373-378

  Murosaki, Shinji ^a   Muroyama, Koutarou ^a   Yamamoto, Yoshihiro ^a   Kusaka, Hiroaki ^a   Liu, Tiei ^b   Yoshikai, Yasunobu ^b  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endogenous infection; IFN ; IL 12; Nigerooligosaccharides; T helper 1

Indexed keywords

CONCANAVALIN A; DISACCHARIDE; FLUOROURACIL; GAMMA INTERFERON; INTERLEUKIN 12; LAMINARIBIOSE; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; OLIGOSACCHARIDE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DIET; ENTEROBACTER INFECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GERMFREE ANIMAL; IMMUNOLOGY; LACTOBACILLUS; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; MUCOSAL IMMUNITY; SPLEEN; TH1 CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; CELLS, CULTURED; CONCANAVALIN A; DIET; DISACCHARIDES; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI INFECTIONS; FEMALE; FLUOROURACIL; IMMUNITY, MUCOSAL; INTERFERON TYPE II; INTERLEUKIN-12; LACTOBACILLUS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; OLIGOSACCHARIDES; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; TH1 CELLS;

EID: 0033073906     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.63.373     Document Type: Article

References (26)

1. Bohn, J. A., and Be Miller, N., (l-»3)-β-D-Glucans as biological response modifiers: a review of structure-functional activity relationships. Carbohydr. Polym., 28, 3-14 (1995).
2. Taguchi, T., Furue, H., Kimura, T., Hattori, T., Itoh, I., and Ogawa, N., End-point results of phase III study of lentinan. Gan To Kagaku Ryoho (in Japanese), 12, 366-378 (1985).
3. Okamura, K., Suzuki, M., Chihara, T., Fujiwara, A., Fukuda, T., Goto, S., Ichinohe, K., Jimi, S., Kasamatsu, T., Kawai, N., Mizoguchi, K., Mori, S., Nakano, H., Noda, K., Sekiba, K., Suzuki, K., Suzuki, T., Takahashi, K., Takeuchi, K., Takeuchi, S., Yajima, A., and Ogawa, N., Clinical evaluation of shizophyl-lan combined with irradiation in patients with cervical cancer. A randomized controlled study. Cancer, 58, 865-872 (1986).
4. Macatonia, S. E., Hsieh, C-S., Murphy, K. M., and O’Garra, A., Dendritic cells and macrophages are required for Thl development of CD4+ T cells from ap TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-y production is IFN-y-dependent. Int. Immunol., 5, 1119-1128 (1993).
5. Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Sherman, F., Perussia, B., and Trinchieri, G., Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med., 170, 827-845 (1989).
6. Arase, H., Arase, N., and Saito, T., Interferon y production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking. J. Exp. Med., 183, 2391-2396 (1996).
7. Ross, G. D., and Vetvicka, V., CR3 (CDllb, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions. Clin. Exp. Immunol., 92, 181-184 (1993).
8. Renzo, L. D., Yefenof, E., and Klein, E., The function of human NK cells is enhanced by β-glucan, a ligand of CR3 (CD1 lb/ CD18). Eur. J. Immunol., 21, 1755-1758 (1991).
9. Badger, A. M., Enhanced superoxide production by rat alveolar macrophages stimulated in vitro with biological response modifiers. J. Leuk. Biol., 40, 725-736 (1986).
10. Takeda, Y., Yoshikai, Y., Ohga, S., and Nomoto, K., Augmentation of host defense against Listeria monocytogenes infection by oral administration with polysaccharide RBS (RON). Int. J. Immunopharmac., 12, 373-383 (1990).
11. Takeda, Y., Tanaka, M., Miyazaki, H., Takeo, S., Nomoto, K., and Yoshikai, Y., Analysis of effector T cells against the murine syngeneic tumor MethA in mice orally administered antitumor polysaccharide SPR-901. Cancer Immunol. Immunother., 38, 143-148 (1994).
12. Yoshida, I., Kiho, T., Usui, S., Sakushima, M., and Ukai, S., Polysaccharides in fungi. XXX VII. Immunomodulating activities of carboxymethylated derivatives of linear (l-*3)-a-D-glu-cans extracted from the fruiting bodies of Agrocybe cylindracea and Amanita muscaria. Biol. Pharm. Bull., 19, 114-121 (1996).
13. Konishi, Y., and Shindo, K., Production of nigerose, nigerosyl glucose, and nigerosyl maltose by Acremonium sp. S4G13. Biosci. Biotechnol. Biochem., 61, 439-442 (1997).
14. Murosaki, S., Yamamoto, Y., Ito, K., Inokuchi, T., Kusaka, H., Ikeda, H., and Yoshikai, Y., Heat-killed Lactobacillusplan-tarum L-137 suppresses naturally fed antigen-specific IgE production by stimulation of IL-12 production in mice. J. Allergy. Clin. Immunol., 102, 57-64 (1998).
15. Harper, A. E., Amino acid balance and imbalance, I. Dietary level of protein and amino acid imbalance. J. Nutr., 68, 405-418 (1959).
16. Murosaki, S., Yoshikai, Y., Ishida, A., Nakamura, T., Matsuzaki, G., Takimoto, H., Yuuki, H., and Nomoto, K., Failure of T cell receptor V^ negative selection in murine intestinal intra-epithelial lymphocytes. Int. Immunol., 3, 1005-1013 (1991).
17. Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods, 65, 55-63 (1983).
18. Nomoto, K., Yokokura, T., Yoshikai, Y., Mituyama, M., and Nomoto, K., Induction of lethal infection with indigenous Escherichia coli in mice by fluorouracil. Can. J. Microbiol., 37, 244-247 (1991).
19. Nomoto, K., Yokokura, T., and Nomoto, K., Prevention of 5-fluorouracil-induced infection with indigenous Escherichia coli in tumor-bearing mice by nonspecific immunostimulation. Can. J. Microbiol., 38, 774-778 (1992).
20. Shida, K., Makino, K., Morishita, A., Takamizawa, K., Hachimura, S., Ametani, A., Sato, T., Kumagai, Y., Habu, S., and Kaminogawa, S., Lactobacillus casei inhibits antigen-in-duced IgE secretion through regulation of cytokine production in murine splenocyte cultures. Int. Arch. Allergy Immunol., 115, 278-287 (1998).
21. Tokoro, A., Takewaki, N., Suzuki, K., Mikami, T., Suzuki, S., and Suzuki, M., Growth-inhibitory effect of hexa-yV-acetylchito-hexaose and chitohexaose against Meth-A solid tumor. Chem. Pharm. Bull., 36, 784-790 (1988).
22. Sasaki, T., Abiko, N., Sugino, Y., and Nitta, K., Dependence on chain length of antitumor activity of (l->3)-/?-D-glucan from Alcaligenes faecalis var. myxogenes, IFO 13140, and its acid-degraded products. Cancer Res., 38, 379-383 (1978).
23. Podzorski, R. P., Gray, G. R., and Nelson, R. D., Different effects of native Candida albicans mannan and mannan-derived oligosaccharides on antigen-stimulated lymphoproliferation in vitro. J. Immunol., 144, 707-716 (1990).
24. Shibata, Y., Metzger, W. J., and Myrvic, Q. N., Chitin particle-induced cell-mediated immunity is inhibited by soluble mannan: Mannose receptor-mediated phagocytosis initiates IL-12 production. J. Immunol, 159, 2462-2467 (1997).
25. Thornton, B. P., Vetvicka, V., Pitman, M., Goldman, R. C., and Ross, G. D., Analysis of the sugar specificity and molecular location of the /?-glucan-binding lectin site of complement receptor type 3 (CDllb/CD18). J. Immunol., 156, 1235-1246 (1996).
26. Sallusto, F., Celia, M., Danieli, C., and Lanzavecchia, A., Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products. J. Exp. Med., 182, 389-400 (1995).